Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory Oakes currently holds 54,454 shares of Landos Biopharma, Inc. (LABP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Oakes has been a net neutral trader of LABP stock. They have purchased $0 and sold $0 worth of shares.
Gregory Oakes's most recent insider trade was on May 23, 2024, when they sold 167,724 shares at $0.00 per share.
Gregory Oakes serves as Executive at Landos Biopharma, Inc. (LABP). They have executed 4 insider transactions totaling $0 over their tenure at the company.
Gregory Oakes holds the position of Executive at Landos Biopharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gregory Oakes has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Gregory Oakes was on May 23, 2024, when they sold $0 worth of LABP shares. This transaction involved 167,724 shares at N/A per share.
Gregory Oakes currently owns 54,454 shares of Landos Biopharma, Inc. (LABP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory Oakes's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory Oakes has 4 Form 4 filings on record as an insider at Landos Biopharma, Inc..
Set alerts for Gregory Oakes and 40,000+ other insiders.